Time-dependent changes in opsonin amount associated on nanoparticles alter their hepatic uptake characteristics

International Journal of Pharmaceutics

Volumn 342, Issue 1-2, 2007, Pages 215-221

  Nagayama, Susumu ^a   Ogawara, Ken ichi ^a   Fukuoka, Yoshiko ^a   Higaki, Kazutaka ^a   Kimura, Toshikiro ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Hepatic uptake; Kupffer cells; Opsonins; Polystyrene nanosphere; Receptor mediated uptake

Indexed keywords

IMMUNOGLOBULIN G; NANOPARTICLE; OPSONIN; PHOSPHATIDYLCHOLINE; POLYSTYRENE;

ARTICLE; CELL ISOLATION; CONTROLLED STUDY; KUPFFER CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; WESTERN BLOTTING;

ADSORPTION; ANIMALS; AREA UNDER CURVE; BLOOD PROTEINS; BLOTTING, WESTERN; CELLS, CULTURED; COMPLEMENT C3; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GADOLINIUM; IMMUNOGLOBULIN G; KUPFFER CELLS; LIVER; MALE; NANOPARTICLES; OPSONIN PROTEINS; PARTICLE SIZE; PHOSPHATIDYLCHOLINES; POLYSTYRENES; RATS; RATS, WISTAR; TRYPSIN;

EID: 34547910668     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.04.036     Document Type: Article

References (42)

1. Absolom D.R. Opsonins and dysopsonins: an overview. Methods Enzymol. 132 (1986) 281-349
2. Allemann E., Gravel P., Leroux J.C., Balant L., and Gurny R. Kinetics of blood component adsorption on poly(d, l-lactic acid) nanoparticles: Evidence of complement C3 component involvement. J. Biomed. Mater. Res. 37 (1997) 229-234
3. Andresen T.L., Jensen S.S., and Jorgensen K. Advanced strategies in liposomal cancer therapy: Problems and prospects of active and tumor specific drug release. Prog. Lipid Res. 44 (2005) 68-97
4. Blunk T., Luck M., Calvor A., Hochstrasser D.F., Sanchez J.C., Muller B.W., and Muller R.H. Kinetics of plasma protein adsorption on model particles for controlled drug delivery and drug targeting. Eur. J. Pharm. Biopharm. 42 (1996) 262-268
5. Borchard G., and Kreuter J. The role of serum complement on the organ distribution of intravenously administrated poly(methyl methacrylate) nanoparticles: Effects of pre-coating with plasma and with serum complement. Pharm. Res. 13 (1996) 1055-1058
6. Celli C.M., Gharavi A.E., and Chaimovich H. Opposite β2-glycoprotein I requirement for the binding of infectious and autoimmune antiphospholipid antibodies to cardiolipin liposomes is associated with antibody avidity. Biochim. Biophys. Acta 1416 (1999) 225-238
7. Chonn A., Semple S.C., and Cullis P.R. Association of blood proteins with large unilamellar liposomes in vivo. J. Biol. Chem. 267 (1992) 18759-18765
8. Devine D.V., Wong K., Serrano K., Chonn A., and Cullis P.R. Liposome-complement interactions in rat serum: implications for liposome survival studies. Biochim. Biophys. Acta 1191 (1994) 43-51
9. Devine D.V., and Marjan J.M.J. The role of immunoproteins in the survival of liposomes in the circulation. Crit. Rev. Ther. Drug Carrier Syst. 14 (1997) 105-131
10. Drummond D.C., Meyer O., Hong K., Kirpotin D.B., and Papahadjopoulos D. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol. Rev. 51 (1999) 691-743
11. Furumoto K., Ogawara K., Nagayama S., Takakura Y., Hashida M., Higaki K., and Kimura T. Important role of serum proteins associated on the surface of particles in their hepatic disposition. J. Controlled Release 83 (2002) 89-96
12. Gessner A., Waicz R., Lieske A., Paulke B.R., Mader K., and Muller R.H. Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption. Int. J. Pharm. 196 (2000) 245-249
13. Gessner A., Lieske A., Paulke B.R., and Muller R.H. Influence of surface charge density on protein adsorption on polymeric nanoparticles: analysis by two-dimensional electrophoresis. Eur. J. Pharm. Biopharm. 54 (2002) 165-170
14. Goppert T.M., and Muller R.H. Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting. Int. J. Pharm. 302 (2005) 172-186
15. Hardonk M.J., Dijkhuis F.W.J., Hulstaert C.E., and Koudstaal J. Heterogeneity of rat liver and spleen macrophages in gadolinium chloride-induced elimination and repopulation. J. Leukoc. Biol. 52 (1992) 296-302
16. Ishida T., Kojima H., Harashima H., and Kiwada H. Biodistribution of liposomes and C3 fragments associated with liposomes: evaluation of their relationship. Int. J. Pharm. 205 (2000) 183-193
17. Ishida T., Harashima H., and Kiwada H. Interactions of liposomes with cells in vitro and in vivo: Opsonins and receptors. Curr. Drug Metab. 2 (2001) 397-409
18. Kertesz Z., Yu B.-B., Steinkasserer A., Haupt H., Benham A., and Sim R.B. Characterization of binding of human β2-glycoprotein I to cardiolipin. Biochem. J. 310 (1995) 315-321
19. Knook D.L., and Sleyster E.C.H. Separation of Kupffer and endothelial cells of the rat liver by centrifugal elutriation. Exp. Cell Res. 99 (1976) 444-449
20. Larkin J.M., Sztul E.S., and Palade G.E. Phosphorylation of the rat hepatic polymeric IgA receptor. Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 4759-4763
21. Lazar G., Galen M., and Scherphof G.L. Gadolinium chloride-induced shifts in intrahepatic distributions of liposomes. Biochim. Biophys. Acta 1011 (1989) 97-101
22. Lee C.M., Yeoh G.C., and Olynyk J.K. Differential effects of gadolinium chloride on Kupffer cells in vivo and in vitro. Int. J. Biochem. Cell Biol. 36 (2004) 481-488
23. Leroux J.C., Jaeghere F.D., Anner B., Doelker E., and Gurny R. An investigation on the role of plasma and serum opsonins on the internalization of biodegradable poly(d,l-lactic acid) nanoparticles by human monocytes. Life Sci. 57 (1995) 695-703
24. Luck M., Schroder W., Paulke B.R., Blunk T., and Muller R.H. Complement activation by model drug carriers for intravenous application: determination by two-dimensional electrophoresis. Biomaterials 20 (1999) 2063-2068
25. Moghimi S.M., and Patel H.M. Serum-mediated recognition of liposomes by phagocytic cells of the reticuloendothelial system-The concept of tissue specificity. Adv. Drug Deliv. Rev. 32 (1998) 45-60
26. Moghimi S.M., and Hunter A.C. Recognition by macrophages and liver cells of opsonized phospholipid vesicles and phospholipid headgroups. Pharm. Res. 18 (2001) 1-8
27. Moghimi S.M., Hunter A.C., and Murray J.C. Long-circulating and target-specific nanoparticles: Theory to practice. Pharmacol. Rev. 53 (2001) 283-318
28. Norman M.E., Williams P., and Illum L. Influence of block copolymers on the adsorption of plasma proteins to microspheres. Biomaterials 14 (1993) 193-201
29. Ogawara K., Furumoto K., Takakura Y., Hashida M., Higaki K., and Kimura T. Surface hydrophobicity of particles is not necessarily the most important determinant in their in vivo disposition after intravenous administration in rats. J. Controlled Release 77 (2001) 191-198
30. Ogawara K., Furumoto K., Nagayama S., Minato K., Higaki K., Kai T., and Kimura T. Pre-coating with serum albumin reduces receptor-mediated hepatic disposition of polystyrene nanosphere: implications for rational design of nanoparticles. J. Controlled Release 100 (2004) 451-455
31. Oja C.D., Semple S.C., Chonn A., and Cullis P.R. Influence of dose on liposome clearance: critical role of blood proteins. Biochim. Biophys. Acta 1281 (1996) 31-37
32. Price M.E., Cornelius R.M., and Brash J.L. Protein adsorption of polyethylene glycol modified liposomes from fibrinogen solution and from plasma. Biochim. Biophys. Acta 1512 (2001) 191-205
33. Scherphof G.L., and Kamps J.A.A.M. Receptor versus non-receptor mediated clearance of liposomes. Adv. Drug Deliv. Rev. 32 (1998) 81-97
34. Scherphof G.L., and Kamps J.A.A.M. The role of hepatocytes in the clearance of liposomes from the blood circulation. Prog. Lipid Res. 40 (2001) 149-166
35. Semple S.C., Chonn A., and Cullis P.R. Interactions of liposomes and lipid-based carrier systems with blood proteins: Relation to clearance behaviour in vivo. Adv. Drug Deliv. Rev. 32 (1998) 3-17
36. Sztul E.S., Howell K.E., and Palade G.E. Biogenesis of the polymeric IgA receptor in rat hepatocytes. II. Localization of its intracellular forms by cell fractionation studies. J. Cell Biol. 100 (1985) 1255-1261
37. Vajdova K., Smrekova R., Kukan M., Jakubovsky J., Rooijen N., Horecky J., Lutterova M., and Wsolova L. Endotoxin-induced aggravation of preservation-reperfusion injury of rat liver and its modulation. J. Hepatol. 32 (2000) 112-120
38. Vroman L., Adams A.L., Fischer G.C., and Munoz P.C. Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plasma at interfaces. Blood 55 (1980) 156-159
39. Vroman L., and Adams A.L. Adsorption of proteins out of plasma and solutions in narrow spaces. J. Colloid Interface Sci. 111 (1986) 391-402
40. Willems G.M., Janssen M.P., Pelsers M.M.A.L., Comfurius P., Galli M., Zwaal R.F.A., and Bevers E.M. Role of divalency in the high-affinity binding of anticardiolipin antibody-β2-glycoprotein I complexes to lipid membranes. Biochemistry 35 (1996) 13833-13842
41. Yamaoka K., Nakagawa T., and Uno T. Statistical moments in pharmacokinetics. J. Pharmacokinet. Biopharm. 6 (1978) 547-558
42. Yan X., Kuipers F., Havekes L.M., Havinga R., Dontje B., Poelstra K., Scherphof G.L., and Kamps J.A.A.M. The role of apolipoprotein E in the elimination of liposomes from blood by hepatocytes in the mouse. Biochem. Biophys. Res. Commun. 328 (2005) 57-62